Schiff Nutrition International Articles
Bayer's Xarelto gets EU clearance for PE and prevention of DVT; gives up on Schiff acquisition
21 November 2012
Bayer 3rd-qtr sales leap 11.5%, but profits down on litigation provisions; buys nutra company
30 October 2012
Showing 1-3 of 3 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
